Electra Therapeutics, Inc. Stock: price and insider trades · United States

Electra Therapeutics, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). Between 18 October 2025 and 18 October 2026, 6 insiders published 14 filings.

Not one open-market sale was filed. On the buying side, 1 insider reported 2 purchases totalling €17.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 1 senior executive among the declarants. Orbimed Advisors LLC filed the largest purchase, €13.1M, on 23 September 2026.

The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 23 September 2026, 25 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction.

With 14 filings in twelve months, the company is quieter than the median of 19 filings across the 5,808 companies we follow on the same exchange. Since 2026, the database holds 2 purchases and no sales by insiders of the company.

For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.